Aquilo Capital Management, LLC 13F Holdings · last filed Q1 2025
Aquilo Capital Management, LLC reported 12 securities worth $55.78M in its SEC 13F filing for Q1 2025 (period ended 2025-03-31). Top holdings: AMGN (33.51%), BPMC (13.32%), ARWR (12.57%). Among its top 25 positions this quarter: 1 new, 4 added, 7 trimmed, 2 exited.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | AMGN | AMGEN INC | $18.7M | 33.51% | 60,000 | Added |
| 2 | BPMC | BLUEPRINT MEDICINES CORP | $7.4M | 13.32% | 83,926 | Trimmed |
| 3 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $7.0M | 12.57% | 550,130 | Trimmed |
| 4 | PTGX | PROTAGONIST THERAPEUTICS INC | $4.0M | 7.08% | 81,692 | Added |
| 5 | KYMR | KYMERA THERAPEUTICS INC | $3.8M | 6.80% | 138,521 | Trimmed |
| 6 | DTIL | PRECISION BIOSCIENCES INC | $3.5M | 6.21% | 726,149 | Added |
| 7 | ARVN | ARVINAS INC | $2.5M | 4.54% | 360,766 | Added |
| 8 | RGNX | REGENXBIO INC | $1.9M | 3.48% | 271,302 | Trimmed |
| 9 | ACET | ADICET BIO INC | $1.9M | 3.32% | 2.5M | Trimmed |
| 10 | BCYC | BICYCLE THERAPEUTICS PLC | $1.5M | 2.61% | 171,695 | Trimmed |
| 11 | IMTX | IMMATICS N.V | $1.4M | 2.47% | 304,902 | Trimmed |
| 12 | RPTX | REPARE THERAPEUTICS INC | $1.3M | 2.29% | 1.3M | Hold |
| 13 | ZYME | ZYMEWORKS INC | $1.0M | 1.80% | 84,482 | New |
| 14 | SLN | SILENCE THERAPEUTICS PLC | $0 | 0.00% | 0 | Exited |
| 15 | STRO | SUTRO BIOPHARMA INC | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2025-03-31
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR